Journal of Biomolecular Screening

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benjamin, E. R.
Right arrow Articles by Woodward, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benjamin, E. R.
Right arrow Articles by Woodward, R. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
This version was published on February 1, 2006
Journal of Biomolecular Screening, Vol. 11, No. 1, 29-39 (2006)
DOI: 10.1177/1087057105280918

State-Dependent Compound Inhibition of Nav1.2 Sodium Channels Using the FLIPR Vm Dye: On-Target and Off-Target Effects of Diverse Pharmacological Agents

Elfrida R. Benjamin

Purdue Pharma L.P., 6 Cedarbrook Drive, Cranbury, NJ 08512 Elfrida.Benjamin{at}pharma.com

Farhana Pruthi

Shakira Olanrewaju

Victor I. Ilyin

Gregg Crumley

Elena Kutlina

Linguagen Corp., Cranbury, NJ

Kenneth J. Valenzano

Amicus Therapeutics, Cranbury, NJ

Richard M. Woodward

Adolor Corporation, Exton, PA

Voltage-gated sodiumchannels (NaChs) are relevant targets for pain, epilepsy, and a variety of neurological and cardiac disorders. Traditionally, it has been difficult to develop structure-activity relationships for NaCh inhibitors due to rapid channel kinetics and state-dependent compound interactions. Membrane potential (V m)dyes in conjunctionwith a high-throughput fluorescence imaging plate reader (FLIPR) offer a satisfactory 1st-tier solution. Thus, the authors have developed a FLIPR V m assay of rat Na v1.2NaCh. Channels were opened by addition of veratridine, and Vm dye responses were measured. The IC50 values from various structural classes of compounds were compared to the resting state binding constant (K r)and inactivated state binding constant (K i)obtained using patch-clamp electrophysiology (EP). The FLIPR values correlated with Ki but not K r.FLIPRIC50 values fellwithin 0.1-to 1.5-fold of EPKi values, indicating that the assay generally reports use-dependent inhibition rather than resting state block. The Library of Pharmacologically Active Compounds (LOPAC, Sigma) was screened. Confirmed hits arose from diverse classes such as dopamine receptor antagonists, serotonin transport inhibitors, and kinase inhibitors. These data suggest that NaCh inhibition is inherent in a diverse set of biologically active molecules and may warrant counterscreening NaChs to avoid unwanted secondary pharmacology.

Key Words: sodium • channel • membrane potential • inactivation • state dependent • fluorescent imaging plate reader

References

  • Catterall W: Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev1992;72(suppl):815-848.
  • Catterall W: From ionic currents tomolecularmechanisms: the structure and function of voltage-gated sodium channels. Neuron2000;26:13-25.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Clare JJ, Tate SN, Nobbs M, Romanos MA: Voltage-gated sodium channels as therapeutic targets. Drug Discov Today2000;5:506-520.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Catterall WA, Goldin AL, Waxman SG: International Union of Pharmacology, XXXIX. Compendium of voltage-gated ion channels: sodium channels. Pharmacol Rev2003;55:575-578.[Abstract/Free Full Text]
  • Isom LL: Sodium channel beta subunits: anything but auxiliary. Neuroscientist2001;7:42-54.[Abstract]
  • Bean B, Cohen C, Tsien R: Lidocaine block of cardiac sodium channels. J Gen Physiol1983;81:613-642.[Abstract/Free Full Text]
  • Butterworth JT, Strichartz G: Molecularmechanisms of local anesthesia: a review. Anesthesiology1990;72:711-734.[ISI][Medline] [Order article via Infotrieve]
  • Hondeghem L, Katzung B: Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol1984;24:387-423.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kuo C, Bean B: Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons. Mol Pharmacol1994;46:716-725.[Abstract]
  • Kuo C-C, Chen R-S, Lu L, Chen R-C: Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction fromphenytoin and possible therapeutic implications. Mol Pharmacol1997;51:1077-1083.[Abstract/Free Full Text]
  • Kuo C-C, Huang R-C, Lou B-S: Inhibition of Na+ current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels. Mol Pharmacol2000;57:135-143.[Abstract/Free Full Text]
  • Xie X, Lancaster B, Peakman T, Garthwaite J: Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones. Pflugers Arch 1995;430:437-446.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Yang Y-C, Kuo C-C: Inhibition of Na+ current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker. Mol Pharmacol2002;62:1228-1237.[Abstract/Free Full Text]
  • Hille B: Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol1977;69:497-515.[Abstract/Free Full Text]
  • Nau C, Seaver M, Wang S-Y, Wang G: Block of human heart hH1 sodium channels by amitriptyline. J Pharmacol Exp Ther2000;292:1015-1023.[Abstract/Free Full Text]
  • Baxter DF, Kirk M, Garcia AF, Raimondi A, Holmqvist MH, Flint KK, et al: A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels. J Biomol Screen2002;7:79-85.[Abstract]
  • Barnes S, Hille B: Veratridinemodifies open sodium channels. J Gen Physiol 1988;91:421-443.[Abstract/Free Full Text]
  • Vickery RG, Amagasu SM, Chang R, Mai N, Kaufman E, Martin J, et al: Comparison of the pharmacological properties of rat Nav1.8 with rat Nav1.2a and human Nav1.5 voltage-gated sodium channel subtypes using amembrane potential sensitive dye and FLIPR. Receptors and Channels2004;10:11-23.[Medline] [Order article via Infotrieve]
  • Verdoorn T, Draguhn A, Ymer S, Seeburg P, Sakmann B: Functional properties of recombinant rat GABA-A receptors depend upon subunit composition. Neuron1990;4:919-928.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Hamill O, Marty A, Neher E, Sakmann B, Sigworth F: Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch1981;391:85-100.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Ilyin VI, Hodges DD, Whitthemore ER, Carter RB, Cai SX, Woodward RM: V102862 (Co 102862): a potent, broad-spectrum, state-dependent blocker of mammalian voltage-gated sodium channels. Br J Pharmacol2005;144:801-812.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Victory S, Shao B, Goehring RR, Sha D, Kyle DJ, Limberis J, et al: Synthesis and evaluation of pyrimidine and pyrimidinone libraries as voltage-gated sodium channel blockers. Presented at the 226th ACS National Meeting, New York, September 7-11, 2003.
  • Shao B, Victory S, Ilyin VI, Goehring RR, Sun Q, Hogenkamp D, et al: Phenoxyphenylpyridines as novel state-dependent, high-potency sodium channel inhibitors. J Med Chem2004;47:4277-4285.[Medline] [Order article via Infotrieve]
  • Deffois A, Fage D, Carter C: Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Neurosci Lett1996;220:117-120.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Gallant M, Dufresne C, Gareau Y, Guay D, Leblanc Y, Prasit P, et al: New class of potent ligands for the human peripheral cannabinoid receptor. Bioorg Med Chem Lett1996;6:2263-2268.
  • Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, et al: A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA2002;99:17179-17184.[Abstract/Free Full Text]
  • Annoura H, Nakanishi K, Uesugi M, Fukunaga A, Imajo S, Miyamjima A, et al: Synthesis and biological evaluation of new4-arylpiperidines and 4-aryl-4-piperidinols: dual Na+ and Ca 2+channel blockers with reduced affinity for dopamine D2 receptors. Bioorg Med Chem2002;10:371-383.[Medline] [Order article via Infotrieve]
  • Fischer W, Kittner H, Regenthal R, De Sarro G: Anticonvulsant profile of flunarizine and relation to Na+ channel blocking effects. Basic Clin Pharmacol Toxicol2005;94:79-88.
  • Bennett PB, Yazawa K, Makita N, George AL Jr: Molecular mechanism for an inherited cardiac arrhythmia. Nature1995;376:683-685.[CrossRef][Medline] [Order article via Infotrieve]
  • Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, et al: SCN5Amutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell1995;80:805-811.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Ptacek LJ, George AL Jr, Griggs RD, Tawil R, Kallen RG, Barchi RL, et al: Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell1991;67:1021-1027.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Rojas CV, Wang J, Schwartz LS, Hoffman EP, Powell BR, Brown RH Jr: A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis. Nature1991;354:387-389.[CrossRef][Medline] [Order article via Infotrieve]
  • Barber MJ, Starmer CF, Grant AO: Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin: evidence for two use-dependent binding sites. Circ Res1991;69:677-696.[Abstract/Free Full Text]
  • Crumb WJ, Clarkson CW: Characterization of cocaine-induced block of cardiac sodium channels. Biophys J1990;57:589-599.[Medline] [Order article via Infotrieve]
  • Ogata N, Narahashi T: Block of sodium channels by psychotropic drugs in single guinea pig cardiac myocytes. Br J Pharmacol1989;97:905-913.[ISI][Medline] [Order article via Infotrieve]
  • Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch CI: Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther1998;284:208-214.[Abstract/Free Full Text]
  • Almers W, Levinson SR: Tetrodotoxin binding to normal depolarized frog muscle and the conductance of a single sodium channel. J Physiol 1975;247:483-509.[Abstract/Free Full Text]
  • Lawrence JC, Catterall WA: Tetrodotoxin-insensitive sodium channels: binding of polypeptide neurotoxins in primary cultures of rat muscle cells. J Biol Chem1981;256:6223-6229.[Abstract/Free Full Text]
  • Matthews JC, Warnick JE, Albuquerque EX, Eldefrawi ME: Characterization of the electrogenic sodium channel from rat brain membranes using neurotoxin-dependent 22Na uptake. Membrane Biochem1981;4:71-104.
  • Reith ME: [14C]Guanidinium ion influx into Na+ channel preparations from mouse cerebral cortex. Eur J Pharmacol1990;188:33-41.[Medline] [Order article via Infotrieve]
  • Rosenberg RL, Tomiko SA, Agnew WS: Single-channel properties of the reconstituted voltage-regulated Na+ channel isolated from the electroplax of Electrophorus electricus. Proc Natl Acad Sci USA1984;81:5594-5598.[Abstract/Free Full Text]
  • Weiser T: Anovel toxicity-based assay for the identification ofmodulators of voltage-gated Na+ channels. J Neurosci Methods2004;137:79-85.[Medline] [Order article via Infotrieve]
  • Chernoff DM: Kinetic analysis of phasic inhibition of neuronal sodium currents by lidocaine and bupivacaine. Biophys J1990;58:53-68.[Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benjamin, E. R.
Right arrow Articles by Woodward, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benjamin, E. R.
Right arrow Articles by Woodward, R. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?